Cite
Pérez-Guijarro E, Yang HH, Araya RE, et al. Author Correction: Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy. Nat Med. 2021;27(2):355doi: 10.1038/s41591-021-01252-6.
Pérez-Guijarro, E., Yang, H. H., Araya, R. E., El Meskini, R., Michael, H. T., Vodnala, S. K., Marie, K. L., Smith, C., Chin, S., Lam, K. C., Thorkelsson, A., Iacovelli, A. J., Kulaga, A., Fon, A., Michalowski, A. M., Hugo, W., Lo, R. S., Restifo, N. P., Sharan, S. K., Van Dyke, T., Goldszmid, R. S., Weaver Ohler, Z., Lee, M. P., Day, C. P., & Merlino, G. (2021). Author Correction: Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy. Nature medicine, 27(2), 355. https://doi.org/10.1038/s41591-021-01252-6
Pérez-Guijarro, Eva, et al. "Author Correction: Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy." Nature medicine vol. 27,2 (2021): 355. doi: https://doi.org/10.1038/s41591-021-01252-6
Pérez-Guijarro E, Yang HH, Araya RE, El Meskini R, Michael HT, Vodnala SK, Marie KL, Smith C, Chin S, Lam KC, Thorkelsson A, Iacovelli AJ, Kulaga A, Fon A, Michalowski AM, Hugo W, Lo RS, Restifo NP, Sharan SK, Van Dyke T, Goldszmid RS, Weaver Ohler Z, Lee MP, Day CP, Merlino G. Author Correction: Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy. Nat Med. 2021 Feb;27(2):355. doi: 10.1038/s41591-021-01252-6. PMID: 33514948.
Copy
Download .nbib